The "Bayportos" vaccine led to a 61% drop in infant hospitalizations due to the RSV virus last winter • Referrals to community clinics dropped by about 40%, and the load in intensive care for babies was cut in half • Despite the success, the Ministry of Health replaces the vaccine with a competing product due to price considerations in the tender • "The supplier was chosen legally, both products are effective and safe"